Cargando…
Preserved arterial vasodilatation via endothelial protease-activated receptor-2 in obese type 2 diabetic mice
BACKGROUND AND PURPOSE: In non-obese diabetic animals, protease-activated receptor-2 (PAR2) agonists are more effective vasodilators, which is attributed to increased COX-2 and endothelial NOS (eNOS) activities. Under conditions of diabetes and obesity, the effectiveness of PAR2 agonists is unknown....
Autores principales: | Kagota, Satomi, Chia, Elizabeth, McGuire, John J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3174416/ https://www.ncbi.nlm.nih.gov/pubmed/21426317 http://dx.doi.org/10.1111/j.1476-5381.2011.01356.x |
Ejemplares similares
-
Protection of protease-activated receptor 2 mediated vasodilatation against angiotensin II-induced vascular dysfunction in mice
por: Chia, Elizabeth, et al.
Publicado: (2011) -
Characterization and Functions of Protease-Activated Receptor 2 in Obesity, Diabetes, and Metabolic Syndrome: A Systematic Review
por: Kagota, Satomi, et al.
Publicado: (2016) -
Apixaban Enhances Vasodilatation Mediated by Protease-Activated Receptor 2 in Isolated Rat Arteries
por: Villari, Ambra, et al.
Publicado: (2017) -
Modulation of Vasomotor Function by Perivascular Adipose Tissue of Renal Artery Depends on Severity of Arterial Dysfunction to Nitric Oxide and Severity of Metabolic Parameters
por: Kagota, Satomi, et al.
Publicado: (2022) -
Small caliber arterial endothelial cells calcium signals elicited by PAR2 are preserved from endothelial dysfunction
por: Hennessey, John C, et al.
Publicado: (2015)